JNJ JNJ ジョンソン・エンド・ジョンソン

 JNJのチャート


 JNJの企業情報

symbol JNJ
会社名 Johnson_Johnson (JNJ ジョンソン・エンド・ジョンソン)
分野(sector)   
産業(industry)   
業種 医薬品   医療関連(Health Care)
概要 事業概要 ジョンソン・アンド・ジョンソン(Johnson_Johnson)は医療分野において各種製品の研究・開発・製造・販売に従事する持株会社である。同社は消費者、医薬品、医療デバイスという3つの事業区分により構成される。同社は人間の健康と幸福に関連する商品を中心に提供する。消費者事業はベビー・ケア、口腔ケア、スキン・ケア、市販薬、女性の健康と創傷ケア市場に使用される各種製品を含む。医薬品事業は免疫学、感染症、神経科学、腫瘍学、心臓血管と代謝疾患を含む5つの治療分野を中心とする。医療デバイス事業は整形外科、外科手術、心臓血管、糖尿病ケア及び視力ケア分野に使用される製品を含む。研究施設は米国、ベルギー、ブラジルカナダ中国、フランス、ドイツ、インド、イスラエル、日本、オランダ、シンガポール、スイス、英国に位置する。  ジョンソン&ジョンソンは、医療・ヘルスケア製品を提供する米国の持株会社。事業部門は、消費者関連、医薬品、医療機器・診断で構成。目薬、鎮痛剤、胃腸薬などの一般用医薬品や栄養補助食品、抗感染、精神疾患、心循環器などの治療薬を製造、販売する。また、病院で使用される外科手術製品・臨床検査機器・診断薬を扱う。本社はニュ―ジャ―ジ―州。  Johnson & Johnson believes good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, Johnson & Johnson has aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, Johnson & Johnson is committed to using its reach and size for good. Johnson & Johnson strives to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. Johnson & Johnson is blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.
本社所在地 One Johnson_Johnson Plaza New Brunswick NJ 08933 USA
代表者氏名 Alex Gorsky
代表者役職名 Chairman of the Board Chief Executive Officer
電話番号 +1 732-524-2455
設立年月日 1887年11月
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 135100人
url www.jnj.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 29362.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 372228.90000
売上高 売上高(百万ドル) 81581.00000
企業価値(EV) 企業価値(EV)(百万ドル) 383021.90000
当期純利益 当期純利益(百万ドル) 15297.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 30 December 2018 Johnson_Johnson revenues increased 7% to $81.58B. Net income before extraordinary items increased 7% to $15.3B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income also reflects Interest Income increase of 59% to $611M (income) Restructuring decrease of 19% to $251M (expense).

 JNJのテクニカル分析


 JNJのニュース

   Johnson & Johnson''s Big Purchase, Amazon''s New Moves, and More  2022/11/05 14:45:00 The Motley Fool
Plus, we run through some shortcuts that could help you with your financial planning.
   Is Johnson & Johnson''s Purchase of Abiomed Good for Investors?  2022/11/05 11:25:00 The Motley Fool
The $16.6 billion acquisition shakes up MedTech.
   Cramer’s lightning round: Cano Health is a buy  2022/11/05 00:34:13 Newslanes
Hasbro Inc: “I actually don’t even like the toy companies right now. … Let’s wait for now.” Viatris Inc: “I don’t like those guys. I do think that [Johnson & Johnson] is going to spin off its consumer product company, and that’s going to be very, very good.” IAC Inc: “That stock is so down. […] Cramer’s lightning round: Cano Health is a buy
   Of Course Elon Musk Is Being Sued for the Way He’s Mass Firing Twitter Employees  2022/11/04 15:47:17 Thenewrepublic
Just when he thought he’d escaped one Twitter-related lawsuit by buying the platform, Elon Musk finds himself at the center of another. A group of former and current Twitter employees filed suit against the company Thursday night, alleging that they were not provided enough notice of their layoffs, in violation of both federal and California state law. In the suit, the group said that one member was fired effective immediately, instead of receiving the required 60-days notice. Three others were locked out of their Twitter accounts before they had been formally notified of a layoff or given advance notice. The billionaire, who definitely bought Twitter because he “ loves humanity ,” clearly thought he was above the federal law prohibiting mass layoffs without at least 60 days advance notice. His week-long reign has been nothing short of shambolic. Musk bought Twitter last Friday for $44 billion, after a court ordered him to complete the deal when he tried to back out of it. He promptly fired most of the top executives and the entire board of directors.
   KEATING INVESTMENT COUNSELORS INC Buys 2, Sells 3 in 3rd Quarter  2022/11/03 23:00:17 GuruFocus
Related Stocks: STIP , AEM , HLN , JNJ , HD ,
   Check Out What Whales Are Doing With JNJ  2022/07/08 21:08:07 Benzinga
A whale with a lot of money to spend has taken a noticeably bearish stance on Johnson & Johnson . Looking at options history for Johnson & Johnson (NYSE: JNJ ) we detected 15 strange trades. If we consider the specifics of each trade, it is accurate to state that 20% of the investors opened trades with bullish expectations and 80% with bearish. From the overall spotted trades, 9 are puts, for a total amount of $831,791 and 6, calls, for a total amount of $203,868. What''s The Price Target? Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $190.0 for Johnson … Full story available on Benzinga.com
   EMA looking into neurodevelopmental risks associated with J&J''s seizure med Topamax (JNJ)  2022/07/08 14:58:24 Seeking Alpha
The European Medicines Agency (EMA) has begun a review into the potential risk of neurodevelopmental disorders in children whose mothers took Johnson & Johnson Topamax while pregnant.
   7 Best Bear Market Stocks to Buy in July 2022  2022/07/07 13:38:22 InvestorPlace
Some may be trying to call a bottom with stocks, but many more believe the rout could continue . With this, it’s best to stay cautious. Instead of diving into more speculative stocks, stick with the best bear market stocks instead. What do I mean when I say, “bear market stocks?” Stocks that perform well during a market downturn. A better phrase to describe them may be defensive stocks. These are the shares in steady, consistently profitable companies, that hold steady during a bear market and continue paying out dividends. You won’t “get rich” with a bear market portfolio. You will, however, be able to possibly lessen losses during the downturn, protecting your capital while the downturn carries on. 7 Oversold Stocks to Buy in July 2022 So, what are the best bear market stocks to buy today? Consider these seven, high-quality names that have been resilient thus far in this year’s market downturn, and will likely stay steady. Ticker Company Current Price JNJ Johnson & Johnson $178.30 LMT Lockheed Martin $425.89 PEP Pepsico $170.70 PFE Pfizer $52.75 PM Philip Morris International $95 UL Unilever $46.18 UNH UnitedHealth Group $515.29 Johnson & Johnson (JNJ) Johnson & Johnson (NYSE: JNJ ) is a stock that needs little introduction.
   Hormel, Chevron, and 7 Other Dividend Aristocrat Stocks That Could Ride Out a Recession  2022/07/07 12:38:00 Barron''s
Hormel, Exxon Mobil, and Johnson & Johnson are among the longtime dividend growers that meet the criteria Barron''s set to determine recession-resilient stocks.
   Johnson & Johnson – Consensus Indicates Potential 6.5% Upside  2022/07/07 10:54:25 DirectorsTalk
Johnson & Johnson found using ticker (JNJ) now have 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 215 and 173 and has a mean target at 189.67. Given that the stocks previous close was at 178.14 this now indicates there is a potential upside of 6.5%. The day 50 moving average is 177.49 and the 200 moving average now moves to 170.41. The market capitalisation for the company is $469,179m. Find out more information at: https://www.jnj.com [stock_market_widget type="chart" template="basic" color="green" assets="JNJ" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $499,546m based on the market concensus. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company''s Consumer Health segment offers baby care products under the JOHNSON''S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
   7 Best Bear Market Stocks to Buy in July 2022  2022/07/07 13:38:22 InvestorPlace
Some may be trying to call a bottom with stocks, but many more believe the rout could continue . With this, it’s best to stay cautious. Instead of diving into more speculative stocks, stick with the best bear market stocks instead. What do I mean when I say, “bear market stocks?” Stocks that perform well during a market downturn. A better phrase to describe them may be defensive stocks. These are the shares in steady, consistently profitable companies, that hold steady during a bear market and continue paying out dividends. You won’t “get rich” with a bear market portfolio. You will, however, be able to possibly lessen losses during the downturn, protecting your capital while the downturn carries on. 7 Oversold Stocks to Buy in July 2022 So, what are the best bear market stocks to buy today? Consider these seven, high-quality names that have been resilient thus far in this year’s market downturn, and will likely stay steady. Ticker Company Current Price JNJ Johnson & Johnson $178.30 LMT Lockheed Martin $425.89 PEP Pepsico $170.70 PFE Pfizer $52.75 PM Philip Morris International $95 UL Unilever $46.18 UNH UnitedHealth Group $515.29 Johnson & Johnson (JNJ) Johnson & Johnson (NYSE: JNJ ) is a stock that needs little introduction.
   Hormel, Chevron, and 7 Other Dividend Aristocrat Stocks That Could Ride Out a Recession  2022/07/07 12:38:00 Barron''s
Hormel, Exxon Mobil, and Johnson & Johnson are among the longtime dividend growers that meet the criteria Barron''s set to determine recession-resilient stocks.
   Johnson & Johnson – Consensus Indicates Potential 6.5% Upside  2022/07/07 10:54:25 DirectorsTalk
Johnson & Johnson found using ticker (JNJ) now have 18 analysts covering the stock. The analyst consensus points to a rating of ''Buy''. The range between the high target price and low target price is between 215 and 173 and has a mean target at 189.67. Given that the stocks previous close was at 178.14 this now indicates there is a potential upside of 6.5%. The day 50 moving average is 177.49 and the 200 moving average now moves to 170.41. The market capitalisation for the company is $469,179m. Find out more information at: https://www.jnj.com [stock_market_widget type="chart" template="basic" color="green" assets="JNJ" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $499,546m based on the market concensus. Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company''s Consumer Health segment offers baby care products under the JOHNSON''S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR.
   J&J Talc Judge Weighs Expert Help to Value Cancer Claims  2022/07/06 21:02:00 The Wall Street Journal
Johnson & Johnson wants to estimate its talc-related liabilities in bankruptcy court. A judge says he may need extra help to do that.
   Bankruptcy judge considers independent valuation of J&J cancer claims  2022/07/06 20:20:08 Reuters
A U.S. bankruptcy judge said on Wednesday that he may appoint an independent expert to assess the value of lawsuits alleging that Johnson & Johnson''s talc products caused ovarian cancer and mesothelioma.

 関連キーワード  (医薬品 米国株 JNJ ジョンソン・エンド・ジョンソン JNJ )

 twitter  (公式ツイッターやCEOツイッターなど)

JNJ動画